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PDZ domains are independently folded modules
that typically mediate protein-protein interactions
by binding to the C termini of their target proteins.
However, in a few instances, PDZ domains have
been reported to dimerize with other PDZ domains.
To investigate this noncanonical-binding mode
further, we used protein microarrays comprising vir-
tually every mouse PDZ domain to systematically
query all possible PDZ-PDZ pairs. We then used
fluorescence polarization to retest and quantify inter-
actions and coaffinity purification to test biophysi-
cally validated interactions in the context of their
full-length proteins. Overall, we discovered 37 PDZ-
PDZ interactions involving 46 PDZ domains (30%
of all PDZ domains tested), revealing that dimeriza-
tion is a more frequently used binding mode than
was previously appreciated. This suggests that
many PDZ domains evolved to form multiprotein
complexes by simultaneously interacting with more
than one ligand.
INTRODUCTION
PDZ domains are approximately 90 residues long and were first
identified as regions of sequence homology in diverse signaling
proteins (Cho et al., 1992; Woods and Bryant, 1993). The name
PDZ is derived from the first three proteins in which these
domains were found: PSD-95 (a 95 kDa protein involved in
signaling in the postsynaptic density); Dlg (the Drosophila discs
large protein); and ZO1 (the zonula occludens 1 protein involved
in maintaining epithelial cell polarity). PDZ domains are found in
proteins of diverse function and generally serve as scaffolds for
the localization and assembly of multiprotein complexes (Harris
and Lim, 2001). They are most often found in combination with
other interaction modules and function in a variety of roles that
include directing the specificity of receptor tyrosine kinase-
mediated signaling (Nourry et al., 2003), establishing and main-Chemistry & Biology 18, 1143–115taining cell polarity (Bilder, 2001), directing protein trafficking
(Sheng and Sala, 2001), and coordinating both presynaptic
and postsynaptic-signaling events (Garner et al., 2000).
Most PDZ domain-mediated binding events that have been
described to date involve interactions between PDZ domains
and the C-terminal tails of their target proteins (Ernst et al.,
2009; Songyang et al., 1997). Structural studies have revealed
a conserved binding mode in which a peptide ligand docks in
an elongated groove between the bB strand and the aB helix
of the PDZ domain (Doyle et al., 1996). However, several inter-
actions have been described that do not conform to this canon-
ical-binding mode. For example the PDZ domain of neuronal
nitric oxide synthase (nNOS) interacts with the PDZ domain of
a1-syntrophin (Hillier et al., 1999) and with the second PDZ
domain of PSD95 (Tochio et al., 2000). Both of these interactions
are physiologically relevant (Brenman et al., 1996a, 1996b).
Structurally, the nNOS PDZ domain has a C-terminal b-hairpin
appendage that mimics a C-terminal peptide ligand and docks
in the canonical peptide-binding groove of the a1-syntrophin
and PSD95 PDZ domains (Hillier et al., 1999; Tochio et al.,
2000). PDZ domains have also been found to dimerize in a
back-to-back fashion that leaves their peptide-binding grooves
available. For example PDZ6 of GRIP1, PDZ1 and PDZ2 of
NHERF1, and the PDZ domain of Shank all dimerize in this
fashion (Fouassier et al., 2000; Im et al., 2003a, 2003b). In addi-
tion the NHERF1 homodimer has been shown to occur in vivo
(Maudsley et al., 2000). This alternative binding mode may
provide a way for PDZ domains to mediate the assembly of
multiprotein complexes by simultaneously interacting with two
different targets.
Despite these early findings, very few additional PDZ-PDZ
interactions have been reported, and the overall frequency of
this binding mode remains unclear. With the goal of discovering
additional interactions and establishing the prevalence of this
noncanonical-binding mode, we devised a strategy to examine
all possible PDZ-PDZ interactions among a large set of mouse
PDZ domains. Our approach combines the throughput of protein
microarrays and the fidelity of solution-phase fluorescence
polarization (FP) with coaffinity purification as a general way to
discover and verify novel interactions (Figure 1A). Using this
systematic, family-wide approach, we identified a total of 37
PDZ-PDZ interactions involving 46 PDZ domains (30% of all2, September 23, 2011 ª2011 Elsevier Ltd All rights reserved 1143
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Figure 1. Strategy for the Discovery and Biophysical Validation of PDZ-PDZ Interactions
(A) Strategy to query PDZ-PDZ interactions on a proteome-wide scale. Protein microarrays are used to independently screen all 12,403 possible PDZ-PDZ
interactions within a set of 157 mouse PDZ domains. Array-positives are then retested and quantified by FP, thereby removing array false-positives. Finally,
PDZ-PDZ biophysically validated PDZ-PDZ interactions are tested for their ability to mediate protein-protein interactions when returned to the context of their
full-length parent proteins.
(B) Pilot PDZ domain microarray, probed with Cy5-labeled nNOS PDZ domain. The microarray comprises 96 distinct PDZ domains derived from the mouse
proteome, spotted in quadruplicate. The green image (Cy3) shows the location of the PDZ domain spots. The red image (Cy5) showswhich PDZ domains are able
to interact with nNOS PDZ. In the Cy5 image the white boxes represent interactions of nNOS PDZ domain with the following domains: (i) a1-Syntrophin PDZ;
(ii) PSD95 PDZ2; (iii) Chapsyn110 PDZ2; (iv) Rgs12 PDZ; (v) ZO1 PDZ1; and (vi) His6-Thioredoxin.
(C) Development of an FP assay for detecting and quantifying PDZ-PDZ interactions. The upper plot shows the nNOS PDZ::a1-Syntrophin PDZ heterodimer, and
the lower plot shows the GRIP1 PDZ6 homodimer. The filled circles represent PDZ-PDZ interactions, and the open circles represent negative controls (Cy3-PDZ
domain mixed with His6-Thioredoxin). KD values were obtained by fitting the data to Equation 1.
See also Tables S1 and S2.
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Proteome-wide PDZ-PDZ InteractionsPDZ domains tested) and found that many of them mediate
stable protein-protein interactions when returned to the context
of their full-length proteins. We conclude that PDZ domain
dimerization is a more frequently used binding mode than was
previously appreciated and submit that many PDZ domains
evolved to help assemble multiprotein complexes by simul-
taneously interacting with more than one ligand. Because
PDZ-PDZ interactions appear to be much more selective than
PDZ-peptide interactions, it is possible that they contribute
more to defining the precise composition of protein complexes1144 Chemistry & Biology 18, 1143–1152, September 23, 2011 ª201than do canonical interactions. Overall, this study uncovered
many previously unrecognized protein-protein interactions and
serves as a launching point for further investigation of their
biological function.
RESULTS AND DISCUSSION
Pilot Experiment Using PDZ Domain Microarrays
To assess the feasibility of using protein microarray technology
to systematically screen all possible PDZ-PDZ pairs, we set1 Elsevier Ltd All rights reserved
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Proteome-wide PDZ-PDZ Interactionsout to study interactions between the PDZ domain of nNOS and
a representative subset of mouse PDZ domains. We began by
assembling a diverse set of 96 mouse PDZ domains (see Table
S1 available online), in addition to the nNOS PDZ domain. To
abstract individual domains from their full-length proteins, we
determined their boundaries by aligning their sequences using
ClustalW, a general-purpose multiple-sequence alignment
program (http://www.ebi.ac.uk/clustalw/). We then used avail-
able structural information to confirm that the boundaries were
defined appropriately. The sequence motif GLGF is present in
many PDZ domains and forms a carboxylate-binding loop
between the first b strand and first a helix. We defined the N
termini of our PDZ domain constructs at 15 residues before
this motif. Because several studies have shown that additional
sequence is required beyond the C termini of PDZ domains to
stabilize PDZ-PDZ interactions (Hillier et al., 1999; Maudsley
et al., 2000; Utepbergenov et al., 2006; Xu et al., 1998), we
included a minimum of 30 additional residues past the predicted
end of each PDZ domain in our constructs. When the PDZ
domain was located within 30 residues of another domain or
occurred at the C terminus of its parent protein, additional
sequence was added up to the start of the next domain or to
the end of the protein, respectively.FP= ðFPmax  FP0Þ
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ðKD + ½probe+ ½PDZÞ24½probe½PDZ
q
2½probe + FP0; (1)PDZ domains were produced recombinantly in Escherichia
coli, as previously described (Stiffler et al., 2007). The domains
featured N-terminal thioredoxin and His6 tags and were purified
in a single step by immobilized metal affinity chromatography.
All of the PDZ domains were verified to be pure, as judged by
SDS-polyacrylamide gel electrophoresis, and monomeric, as
judged by analytical size exclusion column chromatography
(Stiffler et al., 2007).
We have previously reported ways to prepare microarrays of
functional proteins in individual wells of 96-well microtiter plates
(Stiffler et al., 2006). Briefly, recombinant proteins are microar-
rayed onto aldehyde-displaying glass substrates that are cut to
the size of a microtiter plate. Separate arrays are prepared at
the appropriate spacing on each substrate, and the substrates
are subsequently attached to the bottomof bottomlessmicrotiter
plates using intervening silicone gaskets. Following this proce-
dure the 96 purified PDZ domains were printed in quadruplicate,
along with a negative control (His6-tagged thioredoxin). All
domainsweremixedwith a trace amount (100nM) ofCy3-labeled
bovine serum albumin (BSA) and printed at the same concentra-
tion (40 mM). The Cy3-labeled BSA was included to facilitate
image analysis. After quenching and blocking the glass surface,
the arrays were probed with a single concentration (0.1 mM) of
Cy5-labeled nNOS PDZ domain. The arrays were then washed,
dried, and scanned for both Cy3 and Cy5 fluorescence (Fig-
ure 1B). The Cy3 image was used to identify the locations of all
printed PDZ domain spots. Visual inspection of the Cy5 image
revealed five specific PDZ-PDZ interactions (Figure 1B).Chemistry & Biology 18, 1143–115Confirmation of Pilot Microarray Hits by FP
As with all high-throughput assays, there is an error rate associ-
ated with identifying positive interactions. To retest each micro-
array-positive, we set out to develop a solution-phase assay that
is both quantitative and can be usedwith reasonable throughput.
FP is often used to detect and measure the affinity of biomolec-
ular interactions. Although it is best suited for detecting interac-
tions between relatively small molecules and large proteins, it
has also been used to detect protein-protein interactions
(Jameson and Seifried, 1999; Yan and Marriott, 2003). Because
FP is a general assay that can be adapted for large-scale studies,
we sought to determine if FP could be used to detect and
quantify PDZ-PDZ interactions.
As an initial test, we focused on two well-characterized pairs
of PDZ domains that dimerize in structurally distinct ways:
the nNOS::a1-syntrophin PDZ domain heterodimer (Brenman
et al., 1996a; Hillier et al., 1999); and theGRIP1 PDZ6 homodimer
(Im et al., 2003b). In each case a low concentration (25 nM) of
Cy3-labeled PDZ domain was mixed with 12 concentrations of
its unlabeled partner. For both the nNOS::a1-syntrophin hetero-
dimer and the GRIP1 PDZ6 homodimer, saturation binding
was observed (Figure 1C). Under equilibrium conditions, the
observed polarization, FP, is described by Equation 1:where FPmax is themaximumpolarization at saturation, FP0 is the
polarization signal in the absence of PDZ domain, [PDZ] is the
total concentration of PDZ domain, [probe] is the total concen-
tration of Cy3-labeled PDZ domain (25 nM), and KD is the equilib-
rium dissociation constant. Both data sets fit well to Equation 1
(R2 > 0.95). In addition the observed affinity of the nNOS::a1-syn-
trophin PDZ domain heterodimer (KD = 0.56 mM) was consistent
with the previously reported value of 0.61 mM (Harris et al., 2001;
Harris and Lim, 2001). To verify that the interactions were
specific to the PDZ domain portion of the recombinant proteins,
His6-tagged thioredoxin was used as a negative control. As
anticipated, no interactions with His6-thioredoxin were observed
(Figure 1C).
Having established this solution-phase assay, we turned our
attention to the pilot microarray screen. Of the five PDZ domains
that were observed to interact with nNOS PDZ (Figure 1B), three
had previously been reported: a1-syntrophin PDZ, PSD95
PDZ2, and Chapsyn110 PDZ2 (Brenman et al., 1996a, 1996b).
The other two PDZ domains (ZO-1 PDZ1 and Rgs12 PDZ) were
novel. All five of these interactions retested as positive (Figure 2).
In addition the observed KD values for nNOS::a1-syntrophin and
nNOS::PSD95 were consistent with previously reported values
(Harris et al., 2001;Tochioetal., 2000).Binding toHis6-thioredoxin
was not observed in either the microarray or FP assays (Figure 2).
Proteome-wide Investigation of PDZ-PDZ Interactions
To gain a proteome-wide view of PDZ-PDZ interactions, we
attempted to clone, express, and purify every PDZ domain2, September 23, 2011 ª2011 Elsevier Ltd All rights reserved 1145
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Figure 2. Retesting and Quantifying Array-Positives by FP
Cy3-labeled nNOS PDZ domain was held at a fixed concentration of 25 nM,
and unlabeled proteins (PDZ domains or His6-Thioredoxin) were added at 12
different concentrations, ranging from 20 mM down to 20 nM. KD values were
obtained by fitting the data to Equation 1. Unlabeled proteins were as follows:
(A) a1-Syntrophin PDZ; (B) PSD95 PDZ2; (C) Chapsyn110 PDZ2; (D) Rgs12
PDZ; (E) ZO1 PDZ1; and (F) His6-Thioredoxin. See also Tables S1 and S2.
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Proteome-wide PDZ-PDZ Interactionsencoded in the mouse genome. In total we obtained soluble
protein of the correct molecular weight for 157 domains (Table
S2) (Stiffler et al., 2007). PDZ domain microarrays were prepared
by printing the domains, in quadruplicate, in individual wells
of 96-well microtiter plates. To assess all 157 3 158 O 2 =
12,403 possible PDZ-PDZ dimers, we labeled each purified
PDZ domain individually with Cy5 and probed the PDZ domain
microarrays, in triplicate, with 100 nM of each domain (see, for
example, Figure 3A). Intensities for each interaction were ob-
tained by taking the mean fluorescence of replicate spots. Z
scores (calculated as the number of standard deviations a value
is above or below the mean) were generated using the mean
intensity of all interactions for each probe (Table S3). Seven
Cy5-labeled PDZ domains exhibited excessive background
binding on the arrays and so were excluded from subsequent
analyses. Because our primary goal was to discover novel inter-
actions, we used a very low Z-score threshold (1.7) to identify hits
(Figure 3A; Table S3). This strategy minimizes the number of
false-negative interactions but incurs a high false-positive rate.
However, we adopted this conservative approach because our
secondary assay (FP) was compatible with large-scale studies.1146 Chemistry & Biology 18, 1143–1152, September 23, 2011 ª201Because the recombinant PDZ domains had been abstracted
from their full-length parent proteins, most of them featured non-
physiological C termini. It is possible that some of the PDZ-PDZ
interactions that we observed on the arrays occurred because
one PDZ domain recognized the artificial C terminus of its
binding partner. To exclude such artifacts, we evaluated the
potential of each C-terminal tail to serve as a ligand for any of
the 157 mouse PDZ domains using our previously published
PDZ domain-peptide binding data and our predictive models
(Chen et al., 2008; Stiffler et al., 2007). PDZ domains with C
termini that could potentially serve as ligands were modified:
their three C-terminal amino acids were changed to Gly-Gly-
Gly. As demonstrated by two independent, large-scale studies
of PDZ domains and peptides (Chen et al., 2008; Stiffler et al.,
2007), this change precludes their C termini from being recog-
nized by other PDZ domains. These mutant PDZ domains (Fig-
ure S1) were used in place of their nonmutated counterparts in
all subsequent assays.
To eliminate false-positives in the PDZ domain microarray
data set, we retested and quantified all array-positives using
our solution-phase FP assay (Table S4). As an additional level
of redundancy, each heterodimeric interaction was tested twice,
with one or the other domain serving as the Cy3-labeled FP
probe. Overall, 628 twelve-point titrations were performed, rep-
resenting 314 unique PDZ-PDZ interactions. Of these 314 unique
interactions, 100 involved at least 1 PDZ domain that had been
replaced by a Gly-Gly-Gly C-terminal mutant. Interactions with
a KD <25 mM that fit well to Equation 1 (R
2 > 0.95) were scored
as ‘‘positive.’’ On the basis of these criteria, 46 of the 157 PDZ
domains (30%) were involved in at least one interaction (Fig-
ure 3B and Table 1). Overall, 37 PDZ-PDZ interactions were
identified and quantified, 33 of which had not previously been
reported (Table 1).
Further Investigation of PDZ-PDZ Interactions
by Coaffinity Purification
To determine if the observed PDZ-PDZ interactions can mediate
protein-protein interactions in the context of their full-length
parent proteins and in a cellular environment, a subset of PDZ-
PDZ interaction pairs with KD <5 mM was chosen and tested
using a co-AP assay. Full-length or near full-length open reading
frames (ORFs) encoding 15 different proteins were cloned into
Gateway-compatible mammalian expression vectors to gen-
erate Myc- and HA-tagged proteins (Table S5). The constructs
were cotransfected into HEK293T cells, the cells were lysed,
and soluble protein complexes were immunoprecipitated using
an anti-Myc antibody. HEK293T cells singly transfected with
HA-tagged expression constructs served as negative controls.
In total we tested 11 PDZ-PDZ interactions (2 known and 9
novel) using co-AP assays. As anticipated, the two previously re-
ported PDZ-PDZ-mediated interactions—nNOS::Chapsyn110
(Brenman et al., 1996b) and GRIP1::GRIP1 (Im et al., 2003b)—
were detected (Figure 4A). Heterodimerization of GRIP1 with
GRIP2 and homodimerization of GRIP2 were also observed
(Figure 4B). However, it should be noted that although these
latter two protein-protein interactions had previously been
reported (Srivastava et al., 1998), no specific PDZ-PDZ inter-
actions had been assigned to them (GRIP1 and GRIP2 both
contain more than one PDZ domain). More importantly, the1 Elsevier Ltd All rights reserved
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Figure 3. PDZ-PDZ Interactions
(A) PDZ-PDZ interaction matrix determined using
protein microarrays. Interactions with a Z score
R1.7 were designated as array-positives and are
represented by colors, ranging from high Z scores
(white) to low Z scores (dark blue). Array-negatives
(Z score <1.7) are shown in black. Numerical
values for Z scores are provided in Table S3.
(B) Quantitative PDZ-PDZ interaction matrix
determined by FP. Array-positives were retested
and quantified by solution-phase FP. Interactions
with a KD <25 mMare shown in colors, ranging from
high affinity (dark blue) to low affinity (light gray).
Negative interactions (undetectable or KD >25 mM)
are shown in white. Numerical values for all KD
values are provided in Table S4. See also Figure S1
and Table S3 and Table S4.
Chemistry & Biology
Proteome-wide PDZ-PDZ Interactionsco-AP assays scored positive for all seven novel protein-protein
interactions that we tested: GRIP2::Tiam2, CIPP::Syntenin,
nNOS::SAP102, PAR3B::CASK, Rapgef6::nIL16, SAP97::nNOS,Chemistry & Biology 18, 1143–1152, September 23, 2011 ªand MUPP1::MPP2 (Figure 4C). Western
blots illustrating the expression of both
Myc- and HA-tagged full-length proteins
and of b-actin in lysates from transfected
HEK293T cells are shown for all tested
interactions (Figures 4A–4C).
PDZ Dimerization Is Implicated
in the Assembly of Multiprotein
Complexes
To probe the physiological relevance of
these seven novel protein-protein interac-
tions, we used the Gene Ontology (GO)
database (http://www.geneontology.org/)
to examine the cellular components
(localization), biological processes, and
molecular functions associated with
each protein. Not surprisingly, their bio-
logical processes and molecular func-
tions differed substantially (Table S6).
However, when we examined the cellular
component classifications, we observed
considerable overlap for each pair of
interacting proteins, providing evidence
for colocalization.
Next, we used the Gene Network
Central pro (GNCPro) tool (Liu et al.,
2010) to determine if our novel pairs of
interacting proteins were also linked
through broader protein networks.
GNCPro contains literature-curated infor-
mation on protein-protein interactions,
gene regulation, and coexpression for
many mammalian proteins. When we
examined the proteins involved in each
novel interaction, along with the proteins
directly connected to them (i.e., one level
out), we found that all of the proteins inour novel interaction pairs were also connected to each other
through previously established relationships (Figure 5). This
lends support to their biological relevance and suggests that2011 Elsevier Ltd All rights reserved 1147
Table 1. PDZ-PDZ Interactions
PDZ Domain 1 PDZ Domain 2 KD (mM)
a
Previously Known
Interactions
a1-Syntrophin nNOS 0.56b,c Brenman et al., 1996a;
Hillier et al., 1999
GRIP2 (6/6) TIAM2 0.59
Chapsyn-110
(2/3)
nNOS 0.66b Brenman et al., 1996b
SAP97 (2/3) nNOS 0.81
PSD95 (2/3) nNOS 0.92b,c Brenman et al., 1996a;
Tochio et al., 2000
GRIP1 (6/7) GRIP1 (6/7) 0.98b Im et al., 2003b
GRIP1 (6/7) GRIP2 (6/6) 0.99
GRIP2 (6/6) GRIP2 (6/6) 1.0
CIPP (3/10) Syntenin (2/2) 2.2
SAP102 (2/3) nNOS 2.3
nNOS Rgs12 2.6
CASK PAR3B (1/3) 2.8
nNOS (1/1) Chapsyn-110
(1/3)
2.8
DLG5 (1/4) HtrA1 3.2
Rapgef6 n-Interleukin
16 (2/4)
3.9
SAP97 (1/3) nNOS (1/1) 4.0
MUPP1 (5/13) MPP2 4.1
PSD95 (1/3) nNOS (1/1) 4.3
n-Interleukin
16 (2/4)
CASK 5.8
PAR3B (3/3) GRIP2 (4/6) 6.1
n-Interleukin
16 (1/4)
Semcap3 (1/2) 7.1
Pdzk3 (1/2) HtrA1 7.9
HtrA3 DLG5 (1/4) 8.2
PAR3B (2/3) CIPP (4/10) 8.2
ZO2 (3/3) Semcap3 (2/2) 8.9
ZO1 (1/3) nNOS 9.6
PAR3B (3/3) MPP5 11.5
CASK GRIP1 (4/7) 11.7
CASK GRIP2 (4/6) 12.0
Syntenin (1/2) PAR6G 12.9
PSD95 (1/3) MPP5 14.2
Pdzk11 Pdzk1 (4/4) 15.1
HtrA1 HtrA1 17.2
GRIP1 (3/7) PAR6G 19.2
D930005D10Rik PTP-BL (1/5) 19.7
Neurabin-2 MUPP1 (9/13) 20.2
HtrA1 PSD95 (3/3) 21.4
a KD values were measured by FP.
b These interactions were previously reported.
c These interactions were shown to be physiologically relevant.
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or physically link proteins with overlapping biological functions.
For example it was previously shown that nNOS interacts with1148 Chemistry & Biology 18, 1143–1152, September 23, 2011 ª201PSD95, which in turn interacts with SAP102 and SAP97 (Masuko
et al., 1999). Here, we find that nNOS interacts directly with both
SAP102 and SAP97 through PDZ-PDZ dimerization, further
strengthening this postsynaptic-signaling complex (Figure 5A).
Similarly, Cask, a membrane-associated guanylate kinase,
associates with the junctional proteins ZO1 and JAM2 (Kam-
berov et al., 2000). JAM2, in turn, interacts with Pard3 (Ebnet
et al., 2003). Here, we find that Pard3 and Cask interact directly
through their PDZ domains, further establishing this epithelial
junctional protein network (Figure 5B). Overall, we submit that
PDZ-PDZ interactions aremore prevalent than previously appre-
ciated and contribute to the formation or strengthening of multi-
protein complexes.
Interestingly, PDZ-PDZ interactions appear to be substantially
more selective than interactions between PDZ domains and the
C termini of their target proteins. Previously, we used large-scale
binding data to build a statistical model that can be used to
predict interactions between mouse PDZ domains and peptide
sequences (Stiffler et al., 2007). When we used this model to
predict interactions on a proteome-wide level, we found that
the 74 PDZ domains covered by our model recognized, on
average, 245 different proteins (Stiffler et al., 2007). In contrast
the 46 PDZ domains that engage in PDZ-PDZ interactions
recognize, on average, 1.7 PDZ domains (Table 1). Interestingly,
in both cases the PDZ domains recognize 1% of possible
ligands (245 of 31,302 C termini in the case of PDZ-peptide
interactions and 1.7 of 157 PDZ domains in the case of PDZ-
PDZ interactions). However, because there are substantially
fewer PDZ domains than proteins in the mammalian proteome,
PDZ-PDZ interactions are much more selective than PDZ-
peptide interactions. Therefore, it is possible that this noncanon-
ical-binding mode contributes more to defining the precise
composition of protein complexes than does the canonical-
binding mode.
Overall, our findings support a domain-oriented approach to
identifying protein-protein interactions and highlight the impor-
tance of this alternative mode of PDZ domain binding. We antic-
ipate that the newly identified interactions highlighted by this
study will serve as a useful launching point for future investiga-
tions of their biological function.
SIGNIFICANCE
Although PDZ domains typically mediate protein-protein
interactions by binding to the C termini of their target
proteins, it has been shown in a few instances that PDZ
domain can also mediate interactions by dimerizing with
another PDZ domain in either a homotypic or heterotypic
fashion. However, following these early reports, very few
additional interactions have been discovered, and the prev-
alence of this binding mode remains unclear. Here, we use
a combination of protein microarrays, high-throughput
solution-phase fluorescence polarization, and coaffinity
purification to systematically identify PDZ-PDZ interactions
across the mouse proteome. In total we identified 37 PDZ-
PDZ interactions involving 46 distinct PDZ domains (30%
of all PDZ domains tested) and found that many of them
mediate stable protein-protein interactions when returned
to the context of their full-length proteins. The observed1 Elsevier Ltd All rights reserved
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Figure 4. Biochemical Validation of PDZ-PDZ-Mediated Protein-Protein Interactions
HEK293T cells were transiently cotransfected with expression constructs encoding Myc- or HA-tagged full-length (or near full-length) PDZ domain-containing
proteins. Cells were lysed 48 hr after transfection, Myc-tagged proteins were immunoprecipitated, and Myc- or HA-tagged proteins were detected by immu-
noblotting.
(A) Western blots showing the previously reported interaction between nNOS and Chapsyn110 (Brenman et al., 1996b) and the previously reported homo-
dimerization of Grip1 (Im et al., 2003b).
(B) Western blots showing interaction between Grip1 and Grip2 and homodimerization of Grip2.
(C) Western blots showing association of GRIP2 with Tiam2, CIPPwith Syntenin, nNOSwith SAP102, PAR3B with CASK, Rapgef6 with nIL16, SAP97 with nNOS,
and MUPP1 with MPP2. Lysates immunoblotted with anti-Myc, anti-HA, and anti-b-actin are shown as transfection and loading controls.
See also Table S5.
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Proteome-wide PDZ-PDZ Interactionsprevalence of PDZ domain dimerization shows that this
binding mode occurs at a higher frequency than previously
appreciated and suggests that many PDZ domains evolved
to guide the assembly of multiprotein complexes. On aChemistry & Biology 18, 1143–115broader level this study shows that focusing on families of
protein-interaction modules provides a viable way to
segment the challenging task of identifying protein-protein
interactions on a proteome-wide scale.2, September 23, 2011 ª2011 Elsevier Ltd All rights reserved 1149
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Figure 5. Protein-Interaction Networks of PDZ Domain-Containing Proteins
Protein-interaction networks were constructed for each of the seven new, biochemically confirmed protein-protein interactions using the GNCPro tool.
Only proteins that had direct connections to the PDZ domain-containing proteins were included in each graph. Networks include: (A) nNOS::SAP102 and
nNOS::SAP97; (B) Pard3::CASK; (C) nIL16::Rapgef6; (D) Grip2::Tiam2; (E) MPP2::MUPP1; and (F) CIPP::Syntenin. See also Table S6.
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Cloning of PDZ domains and production and purification of recombinant
proteins were performed as previously described (Chen et al., 2008; Stiffler
et al., 2006, 2007).
Fluorophore Labeling of PDZ domains
N-hydroxy succinimidyl esters of cyanine-3 (Cy3) and cyanine-5 (Cy5) fluores-
cent dyes were obtained as a dry powder (GE Healthcare, Pittsburgh). Each
vial of dye was dissolved in 100 ml of Buffer A (100 mM KCl, 10 mM
NaH2PO4/Na2HPO4 [pH 7.4]). A total of 20 ml of this dye solution was added
to 200 ml of a room temperature solution of 80 mMPDZ domain in Buffer A. After
30 min at room temperature, the protein/dye solution was diluted to 1 ml using
Buffer A. Immediately after dilution, unreacted dye was separated from dye-
labeled PDZ domain using NAP10 gel permeation chromatographic columns
(GE Healthcare). Protein concentration and protein-to-dye ratios were deter-
mined on the basis of absorbance at 280 and 552 nm (Cy3) or 650 nm (Cy5).
Labeled proteins were aliquoted and stored at 80C.
Manufacturing and Processing of Protein Microarrays
Purified recombinant PDZ domains, doped with 100 nM Cy3-labeled BSA,
were spotted at a concentration of 40 mM onto 112.5 3 74.5 3 1 mm alde-1150 Chemistry & Biology 18, 1143–1152, September 23, 2011 ª201hyde-displaying glass substrates (Erie Scientific Co., Portsmouth, NH) using
a BioChip Arrayer (PerkinElmer, Boston). A total of 96 identical microarrays
were printed in an 8 3 12 pattern on the glass plates, with a pitch of 9 mm.
Each microarray consisted of a 20 3 20 pattern of spots, with a center-to-
center spacing of 250 mm. Proteins were spotted in quadruplicate. Following
an overnight incubation the glass was attached to the bottom of a bottomless
96-well microtiter plate (Greiner Bio-One, Kremsmu¨nster, Austria) using an
intervening silicone gasket (Grace Bio-Labs, Bend, OR). Immediately before
use, the plates were quenched with Buffer A containing 1% BSA (w/v) for
1 hr at room temperature, followed by incubation in Buffer A containing 1%
BSA (w/v) and 50 mM glycine. The arrays were rinsed briefly in Buffer A
containing 0.1% Tween 20 (v/v) and probed with a 0.1 mM concentration of
Cy5-labeled PDZ domain dissolved in Buffer B (100 mM KCl, 1% BSA [w/v],
0.1% Tween 20 [v/v], 10 mM Na2HPO4/NaH2PO4 [pH7.4]). Following a 1 hr
incubation at room temperature, the peptide solution was removed, and the
arrays were washed with 300 ml of Buffer A containing 0.1% Tween 20 (v/v).
The arrays were rinsed twice with 300 ml of ddH2O and spun upside down in
a centrifuge for 60 s to remove residual water.
Scanning and Analysis of Protein Microarrays
PDZ microarrays were scanned at 10 mm resolution using a Tecan LS400
microarray scanner (Tecan, Ma¨nnedorf, Switzerland). Cy5 fluorescence was1 Elsevier Ltd All rights reserved
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Proteome-wide PDZ-PDZ Interactionsimaged using a 633 nm laser, and Cy3 fluorescence was imaged using a
543 nm laser. Images were analyzed using Array-Pro image analysis software
(Media Cybernetics, Bethesda, MD) and MATLAB (MathWorks, Natick, MA).
Microarray spots were identified on the basis of the Cy3 image, and the
mean Cy5 fluorescence of each protein was calculated from the four replicate
spots. Z-score values were determined separately using the mean of all data
points from each Cy5 PDZ domain probe.
Site-Directed Mutagenesis of PDZ Domain C Termini
The coding region for the three C-terminal residues of the PDZ domain was
changed to three consecutive glycines using the QuikChange Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA). Primers were designed using
an online design tool (Stratagene) and ordered as complimentary pairs
(Invitrogen, Carlsbad, CA). Mutant clones were verified by DNA sequencing.
Fluorescence Polarization
Purified recombinant PDZ domains were introduced into separate wells in
column 1 of a 96-well microtiter plate (2 ml/well) at a concentration of
25 mM. The remaining wells of the plate were filled with Buffer A supplemented
with 2.5 mM dithiothreitol (DTT), and 2-fold serial dilutions of each domain
were prepared across each row. DTT was added to all wells in column 1, re-
sulting in a 1.25 mM DTT concentration across all wells. Cy3-labeled PDZ
domains were diluted to a concentration of 100 nM in Buffer A. A 10 ml portion
of Cy3-labeled PDZ probe solution was then transferred to alternating wells of
a row in a 384-well microtiter plate using amultichannel pipette. A 40 ml portion
of a PDZ domain dilution series was then transferred to alternating wells of the
384-well plate using a multichannel pipette, resulting in two separate
PDZ/Cy3-PDZ titrations per row and 32 titrations per 384-well plate. Plates
were incubated at room temperature for 12 hr. After spinning the plates
down, Cy3 fluorescence was detected using an Analyst AD fluorescence
plate reader (Molecular Devices, Sunnyvale, CA), with excitation at 525 nm
and emission at 590 nm. FP, in millipolarization units (mP), was defined as
1033 (Ik  It)/(Ik + It), where Ik and It are the fluorescence intensities parallel
and perpendicular to the plane of incident light, respectively. Data for each
PDZ/Cy3-PDZ interaction were fit to Equation 1 using a general curve-fitting
algorithm (MATLAB). An interaction was scored as ‘‘positive’’ if it fit well
to Equation 1 (R2 R 0.95), had a KD %25 mM, and had a high signal (FP 
FP0R 15 mP at 20 mM PDZ domain).
Mammalian Expression Constructs
Plasmids containing full-length or nearly full-length ORFs for PDZ domain-
containing proteins were obtained commercially (Thermo Scientific-Open
Biosystems, Huntsville, AL). All ORFs were subcloned into the vector
pENTR/D-TOPO by topoisomerase I-mediated directional cloning (Invitrogen).
The coding region for each construct was transferred into the mammalian
expression vectors pCMV-MYC and pCMV-HA (Clontech, Mountain View,
CA) via l-recombinase mediated directional subcloning. Each clone was
verified by DNA sequencing.
Cell Lines and Reagents
HEK293T and HeLa cells were obtained from American Type Culture Collec-
tion (ATCC, Rockville, MD) and maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS),
2 mM glutamine, 100 IU/ml penicillin, and 100 mg/ml streptomycin. Primary
antibodies were obtained from the following sources: mouse anti-MYC (Cell
Signaling Technology, Danvers, MA; catalog #2276); rabbit anti-HA (Cell
Signaling Technology; catalog #3724); andmouse anti-b-actin (Sigma-Aldrich,
Inc., St. Louis; catalog #A1978).
Transfections and Coaffinity Purifications
For cotransfection experiments, cells were grown to 75% confluency in
100 mm dishes. A total of 3 mg of each tagged pCMV plasmid was transfected
into HEK293T cells using Lipofectamine 2000 according to the manufacturer’s
instructions (Invitrogen). After 12 hr, the media were aspirated, and newmedia
were added. Two days after transfections, the cells were washed twice with
cold phosphate-buffered saline, harvested, and lysed with 500 ml of lysis
buffer (Cell Signaling Technology; catalog #9803) supplemented with 1 mM
phenylmethylsulfonyl fluoride and a cocktail of protease inhibitors (RocheChemistry & Biology 18, 1143–115Applied Science, Indianapolis, IN; 1 tablet per 10 ml) on ice for 30 min.
Whole-cell lysates were cleared by centrifugation at 20,000 3 g for 10 min
at 4C.
For co-AP experiments, lysates were incubated with a 1:50 dilution of the
appropriate primary antibody with agitation for 2 hr at 4C, mixed with
a 1:10 dilution of Protein A/G PLUS-Agarose (Santa Cruz Biotechnology;
catalog #SC-2003), and incubated on ice for 1 hr with agitation. Immunopre-
cipitates were pelleted, washed, and resuspended in NuPAGE LDS Sample
Buffer (Invitrogen; catalog #NP0007), and subjected to immunoblotting.
Immunoblotting
Prior to immunoblotting, lysates were boiled in NuPAGE LDS Sample Buffer
and loaded onto NuPAGE Novex 4%–12% Bis-Tris 1.0 mm, 15-well precast
gels (Invitrogen; catalog #NP0323). All solutions and procedures were per-
formed according to manufacturer instructions. After separation by electro-
phoresis, the proteins were transferred to nitrocellulose, and the membranes
were blocked with 5% nonfat dry milk (w/v) in phosphate-buffered saline.
Membranes were probed using a mouse-anti-MYC antibody (Cell Signaling
Technology), a rabbit-anti-HA antibody (Cell Signaling Technology), and/or
a mouse-anti-b-actin antibody (Sigma-Aldrich). Bands were detected with
IRDye 680-labeled goat-anti-rabbit IgG and IRDye 800CW-labeled goat-
anti-mouse (LI-COR Biosciences, Lincoln, NE) and imaged using an Odyssey
Infrared Imaging System (LI-COR Biosciences).SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and six tables and can be found
with this article online at doi:10.1016/j.chembiol.2011.06.013.
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